People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Pharmaceuticals, Other Health Care, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Melinta Therapeutics, Inc. /New/ | — | Pharmaceuticals | Series D+ | $346.8M | $4.9B | 2012 |
| Neuronetics, Inc. | — | Other Health Care | Series B | $118.7M | $332.3M | 2011 |
| Vesper Medical, Inc. | — | Healthtech | Series B | $22.5M | $174.6M | 2019 |
P. Sherill Neff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside P. Sherill Neff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| P. Sherrill Neff | 2 | 8 |
| Bruce J. Shook | 2 | 3 |
| John Johnson | 1 | 25 |
| Garheng Kong | 1 | 16 |
| David Gill | 1 | 8 |
| Dov Goldstein | 1 | 6 |
| Brian Farley | 1 | 5 |
| Richard Kent | 1 | 5 |
| Wilfred Jaeger | 1 | 4 |
| John H Johnson | 1 | 4 |
| DAN SACHS | 1 | 4 |
| Ron Hunt | 1 | 4 |
| I Wistar Morris | 1 | 3 |
| DENNIS W. WAHR | 1 | 3 |
| Leslie Bottorff | 1 | 3 |
| Michael Dale | 1 | 3 |
| Gil Kliman | 1 | 3 |
| John L. Johnson | 1 | 3 |
| Kevin J. Bitterman | 1 | 2 |
| Michael D. Dale | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.